IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Congress pushes FDA to move more quickly on CBD

Language in spending bill gives agency $2 million for work on CBD, urges progress on policy of enforcement discretion and legal path for foods and supplements

This article is powered by Food Chemical News

The FDA spending bill likely to be approved by Congress this week includes $2 million for the agency to study hemp-derived cannabidiol (CBD) and to begin work on an enforcement discretion policy for food and dietary supplements that contain the non-psychoactive cannabis ingredient.

Related Content


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts